Manifestasi neurologis pada COVID-19
Clara Novena Bittikaka(1), Sekar Satiti(2*)
(1) SMF Saraf RS Budi Sehat, Purworejo, Jawa Tengah
(2) Departemen Neurologi Fakultas Kedokteran, Kesehatan Masyarakat, dan Keperawatan, Universitas Gadjah Mada, Yogyakarta/RSUP Dr Sardjito
(*) Corresponding Author
Abstract
Coronavirus (CoV) is a large family of viruses that cause illness ranging from mild to severe symptoms known as Coronavirus Disease 2019 (COVID-19) which is a new type of disease that has never been previously identified in humans. Clinical manifestations appear within 2 to 14 days after exposure. Common signs and symptoms of COVID-19 infection vary from asymptomatic, mild symptoms, severe, to lead to fatal conditions and death. Common symptoms include acute respiratory distress such as fever, fatigue, myalgia, arthralgia, sore throat, cough, sputum production, shortness of breath and gastrointestinal symptoms such as diarrhea, nausea, vomiting, leading to multiple systemic infections and multi-organ failure. Neurological manifestations were found in patients infected with COVID-19 with varied symptoms and there were differences in the grouping of neurological manifestations reported from one literature to another. The neurological manifestations that appear in COVID-19 patients are divided into central nervous system (CNS) and peripheral nervous system (PNS) manifestations, and some are grouped into neurological manifestations with specific symptoms and non-specific symptoms. The neurological manifestations of the CNS include dizziness, headache, impaired consciousness, acute cerebrovascular disease, ataxia, and seizures. Meanwhile, the manifestations of PNS are impaired taste, olfactory disturbances, visual disturbances, pain in nerve distribution, and symptoms of skeletal muscle injury. Writing this literature aims to understand more deeply about neurological manifestations of COVID-19 and its mechanisms that can help determine targeted therapy and reduce the severity and reduce mortality of this disease.
ABSTRAK
Coronavirus (CoV) adalah virus yang menyebabkan penyakit mulai dari gejala ringan sampai berat yang dikenal dengan Coronavirus Disease 2019 (COVID-19). Manifestasi klinis muncul dalam 2 hingga 14 hari setelah paparan. Tanda dan gejala umum infeksi COVID-19 bervariasi mulai dari asimtomatik, gejala ringan, berat, hingga mengakibatkan kondisi yang fatal dan kematian. Gejala umum berupa gejala gangguan pernapasan akut seperti demam, fatigue, mialgia, artralgia, nyeri tenggorokan, batuk, produksi sputum, sesak napas dan gejala gastrointestinal seperti diare, nausea, vomitus hingga menyebabkan infeksi sistemik multipel dan kegagalan multiorgan. Manifestasi neurologis dijumpai pada pasien yang terinfeksi COVID-19 dengan gejala yang bervariasi dan terdapat perbedaan pengelompokan manifestasi neurologis yang dilaporkan antara literatur yang satu dengan yang lainnya. Manifestasi neurologis yang muncul pada pasien COVID-19 terbagi menjadi manifestasi central nervous system (CNS) dan peripheral nervous system (PNS), dan ada pula yang mengelompokkan ke dalam manifestasi neurologis dengan gejala yang spesifik dan gejala nonspesifik. Manifestasi neurologis CNS di antaranya adalah dizziness, nyeri kepala, gangguan kesadaran, acute cerebrovascular disease, ataksia, dan kejang. Sementara untuk manifestasi PNS adalah gangguan pengecapan, gangguan penciuman, gangguan penglihatan, nyeri pada distribusi saraf, dan gejala skeletal muskular injury. Penulisan tinjauan pustaka ini bertujuan untuk mengkaji lebih dalam mengenai manifestasi neurologis pada COVID-19 beserta mekanismenya yang mendasari sehingga dapat membantu menentukan target terapi dan mengurangi derajat keparahan (severitas) serta menurunkan mortalitas penyakit ini.
Keywords
Full Text:
PDF (Bahasa Indonesia)References
WHO Director-General’s remarks at the media briefing on 2019-nCoV on 11 February 2020. n.d. Available from : www.who.int. URL https://www.who.int/dg/speeches/detail/whodirector-general-s-remarks-at-the-media-briefing-on-2019-ncov-on-11-february-2020.
Rothan HA, Byrareddy SN. The Epidemiology and Pathogenesis of Coronavirus Disease (COVID-19) Outbreak. Journal of Autoimmunity. 2020;109:102433.
Ren LL, Wang YM, Wu ZQ, Xiang ZC, Guo L, Xu T, et al.Identification of a novel coronavirus causing severe pneumonia in human: a descriptive study. Chinese Medical Journal. 2020;133(9):1015–1024.
Chang TH, Wu JL, Chang LY. Clinical characteristics and diagnostic challenges of pediatric COVID-19: a systematic review and meta-analysis. Journal of the Formosan Medical Association. 2020 May 1;119(5):982-9.
Meo SA, Alhowikan AM, Khlaiwi TAL, Meo IM, Halepoto DM, Iqbal M, et al. Novel coronavirus 2019-nCoV: Prevalence, biological and clinical characteristics comparison with SARS-CoV and MERS-CoV. European Review for Medical and Pharmacological Sciences. 2020;24(4):2012–2019.
Wu A, Peng Y, Huang B, Ding X, Wang X, Niu P, et al. Genome composition and divergence of the novel coronavirus (2019-nCoV) originating in China. Cell Host Microbe. 2020;27(3):325-328.
Chan JF, To KK, Tse H, Jin DY, Yuen KY. Interspecies transmission and emergence of novel viruses: lessons from bats and birds. Trends in Microbiology. 20131;21(10):544-555.
Kannan SP, Ali PS, Sheeza A, Hemalatha K. COVID-19 (Novel Coronavirus 2019) - recent trends. European Review for Medical and Pharmacological Sciences. 2020;24(4):2006–2011.
Mao L, Jin H, Wang M, Hu Y, Chen S, He Q, et al. Neurologic manifestations of hospitalized patients with Coronavirus Disease 2019 in Wuhan, China. JAMA Neurology. 2020;77(6):683–690.
Guo YR, Cao QD, Hong ZS, Tan YY, Chen SD, Jin HJ, et al. The origin, transmission and clinical therapies on coronavirus disease 2019 (COVID-19) outbreak–an update on the status. Military Medical Research. 2020;7(1):1-10.
Long B, Brady WJ, Koyfman A, Gottlieb M. Cardiovascular complications in COVID-19. The American Journal of Emergency Medicine. 2020;38(7):1504-1507.
Mao R, Qiu Y, He JS, Tan JY, Li XH, Liang J, et al. Manifestations and prognosis of gastrointestinal and liver involvement in patients with COVID-19: a systematic review and meta-analysis. The Lancet Gastroenterology & Hepatology. 2020;5(7):667-678.
Rodriguez-Morales AJ, Cardona-Ospina JA, Gutiérrez-Ocampo E, Villamizar-Peña R, Holguin-Rivera Y, Escalera-Antezana JP, et al. Clinical, laboratory and imaging features of COVID-19: A systematic review and meta-analysis. Travel Medicine and Infectious Disease. 2020;34:101623.
Rochmah MA, Satiti S, Setyopranoto I, Harahap ISK, Sejahtera DP. neurological findings in patients with COVID-19: a systematic review. Journal of the Medical Sciences. 2020;52(3):37–50.
Ghannam M, Alshaer Q, Al-Chalabi M, Zakarna L, Robertson J, Manousakis G. Neurological involvement of coronavirus disease 2019: a systematic review. Journal of neurology. 2020;267(11):3135-3153.
Li Q, Guan X, Wu P, Wang X, Zhou L, Tong Y, et al. Early transmission dynamics in Wuhan, China, of novel coronavirusinfected pneumonia. New England Journal of Medicine. 2020;382(13):1199-1207.
De Wit E, Van Doremalen N, Falzarano D, Munster VJ. SARS and MERS: recent insights into emerging coronaviruses. Nature Reviews Microbiology. 2016;14(8):523-534.
Wu Y, Xu X, Chen Z, Duan J, Hashimoto K, Yang L, et al. Nervous system involvement after infection with COVID-19 and other coronaviruses. Brain, behavior, and immunity. 2020;87:18-22.
Unni SK, Růžek D, Chhatbar C, Mishra R, Johri MK, Singh SK. Japanese encephalitis virus: from genome to infectome. Microbes and Infection. 2011;13(4):312-321.
Desforges M, Le Coupanec A, Dubeau P, Bourgouin A, Lajoie L, Dubé M, et al. Human coronaviruses and other respiratory viruses: underestimated opportunistic pathogens of the central nervous system?. Viruses. 2020;12(1):14.
Swanson PA, McGavern DB. Viral diseases of central nervous system. Current Opinion Virology. 2015;11:44-54.
Koyuncu OO, Hogue IB, Enquist LW. Virus infections in the nervous system. Cell Host Microbe. 2013;13(4):379-393.
Bohmwald K, Galvez N, Ríos M, Kalergis AM. Neurologic alterations due to respiratory virus infections. Frontiers in Cellular Neuroscience. 2018;12:386
Abdennour L, Zeghal C, Deme M, Puybasset L. Interaction brain-lungs. Annales Francaises d’Anesthesie et de Reanimation. 2012;31(6):e101-107.
Fu Y, Cheng Y, Wu Y. Understanding SARS-CoV-2-mediated inflammatory responses: from mechanisms to potential therapeutic tools. Virologica Sinica. 2020;35(3):266-271.
Mehta P, McAuley DF, Brown M, Sanchez E, Tattersall RS, Manson JJ. COVID-19: consider cytokine storm syndrome and immunosuppression. Lancet. 2020;S0140-6736(20):30628.
Chen J, Zhao Y, Chen S, Wang J, Xiao X, Ma X, et al. Neuronal over-expression of ACE2 protects brain from ischemia-induced damage. Neuropharmacology. 2014;79:550-558.
Wan S, Yi Q, Fan S, Lv J, Zhang X, Guo L. et al. Characteristics of lymphocyte subsets and cytokines in peripheral blood of 123 hospitalized patients with 2019 novel coronavirus pneumonia (NCP). medRxiv. 2020.
Aghagoli G, Gallo Marin B, Katchur NJ, Chaves-Sell F, Asaad WF, Murphy SA. Neurological involvement in COVID-19 and potential mechanisms: a review. Neurocritical Care. 2021;34(3):1062-1071.
Baig AM, Khaleeq A, Ali U, Syeda H. Evidence of the COVID-19 virus targeting the CNS: tissue distribution, host–virus interaction, and proposed neurotropic mechanisms. ACS chemical neuroscience. 2020;11(7):995-998.
Bridwell R, Long B, Gottlieb M. Neurologic complications of COVID-19. American Journal of Emergency Medicine. 2020;38:1549.e3-1549.e7.
Reinhold AK, Rittner HL. Barrier function in the peripheral and central nervous system—a review. European Journal of Physiology. 2017;469(1):123-134.
Pilotto A, Odolini S, Masciocchi S, Comelli A, Volonghi I, Gazzina S, et al. Steroid-responsive encephalitis in coronavirus disease 2019. Annals of neurology. 2020;88(2):423-427.
Ahmad I, Rathore FA. Neurological manifestations and complications of COVID-19: a literature review. Journal of Clinical Neuroscience. 2020;77:8-12.
Pinzon RT, Wijaya VO, Buana RB, Al Jody A, Nunsio PN. Neurologic characteristics in coronavirus disease 2019 (COVID-19): a systematic review and meta-analysis. Frontiers in Neurology. 2020;11:565.
Cascella M, Rajnik M, Aleem A, Dulebohn S, Di Napoli R. Features, evaluation, and treatment of coronavirus (COVID-19). StatPearls. 2021.
DOI: https://doi.org/10.22146/bns.v20i1.103669
Article Metrics
Abstract views : 4 | views : 5Refbacks
- There are currently no refbacks.
Copyright (c) 2025 Berkala NeuroSains
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.